City of Hope and Texas Oncology are the first customers for Trapelo, a decision support platform from Innovation Insights that involves labs and payors.
In a pair of recent studies, Crescendo put forth new clinical utility data and an age and adiposity-adjusted model for its Vectra DA rheumatoid arthritis test.
Smaller labs that serve large Medicare populations, such as skilled nursing facility labs, have cut services and expressed concerns about their survival.
The health insurer renewed its longstanding clinical lab services relationship with LabCorp and added Quest as an in-network provider of such services.
Questions posed by CMS about expanding PAMA data collection expose a rift between labs and other industry stakeholders over who should report lab prices.
CareFirst BlueCross BlueShield and United Health Group join six others in FDA's Private Payor Program for providing device makers presubmission feedback.
